Form 8-K - Current report:
SEC Accession No. 0001193125-19-317841
Filing Date
2019-12-19
Accepted
2019-12-18 19:18:09
Documents
15
Period of Report
2019-12-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d831842d8k.htm   iXBRL 8-K 26223
2 EX-99.1 d831842dex991.htm EX-99.1 38124
6 GRAPHIC g831842img1.jpg GRAPHIC 4743
7 GRAPHIC g831842img2.jpg GRAPHIC 7457
  Complete submission text file 0001193125-19-317841.txt   212014

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20191218.xsd EX-101.SCH 3092
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20191218_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20191218_pre.xml EX-101.PRE 10968
10 EXTRACTED XBRL INSTANCE DOCUMENT d831842d8k_htm.xml XML 3271
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 191293819
SIC: 2836 Biological Products, (No Diagnostic Substances)